spacer
home > ict > summer 2019 > finding the right fit
PUBLICATIONS
International Clinical Trials

Finding the Right Fit



 

ICT: Is it preferable to partner with a small, large, or mid-size CRO?

Catherine Konidas: It depends on whether you want to deal with a large company or would prefer having a more direct involvement in your projects. In many cases, mid-size companies may be more flexible, agile, and open to adapting their processes to meet your requirements. The culture of a mid-size organisation usually emphasises responsiveness and client relationships, regardless of the size of your business or programme budget.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author


Catherine Konidas joined Altasciences in 2010 as Vice President of Global Business Development, with the mandate of building a high-performing business development team focused on transforming the company’s commercial offering to cater to the expanding innovator market. Catherine was promoted to Chief Commercial Officer in 2017 and now oversees the company’s commercial strategy, including mergers and acquisitions activity, corporate budgeting, and overall business metrics across the organisation. She started her career at CTBR Bio-Research (now Charles River Laboratories) in 2002, holding a series of positions of increasing responsibility in business development before being appointed Senior Site Director of the Montreal facility, Canada, and leading approximately 1,300 employees. She holds a BA in Psychology and a Master’s in Business Administration.


Print this page
Send to a friend
Privacy statement
News and Press Releases

WuXi STA and Dizal Pharmaceutical Sign CMC Development and Manufacturing Agreement

STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – and Dizal Pharmaceutical, a biotechnology company, announce a strategic partnership. Under the terms of the collaboration, WuXi STA will become the preferred CDMO partner of Dizal Pharmaceutical for GMP production, providing integrated CMC (Chemical, manufacturing and Control) process research and manufacturing services from API to drug product.
More info >>

White Papers

Autoinjector testing made safe efficient and flexible

ZwickRoell

The autoinjector market is one of the fastest growing markets across almost all pharmaceutical applications. Studies expect a global market volume of approximately USD 2.5 billion by 2020, with pre-filled autoinjectors representing the largest market segment. There are a variety of tests that can be performed on autoinjectors, and these are well-demonstrated by the Zwick product portfolio. The Ulm-based company and specialist in testing systems offers a variety of testing systems that are already being successfully used by multiple pharmaceutical companies.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement